Found 544 hits.
| 89 | Metz, M., Scholz, E., Ferrán, M., Izquierdo, I., Giménez-Arnau, A., and Maurer, M.+: Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann. Allergy Asthma Immunol. 2010: 104; 86-92. IF: 2.80 |
| 331 | Maurer, M.+, Houghton, K., Costa, C., Dabove, F., Ensina, L. F., Giménez-Arnau, A., Guillet, G., Konstantinou, G. N., Labrador-Horrillo, M., Lapeere, H., Meshkova, R., Pastorello, E. A., Velásquez-Lopera, M., Tamayo Quijano, L., M.; Vestergaard, C., and Chapman-Rothe, N.: Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study. World Allergy Organ. J. 2018: 11; 32. IF: 3.68 |
o.331
| 414. | Kolkhir, P., Altrichter, S., Asero, R., Daschner, A., Ferrer, M., Giménez-Arnau, A., Hawro, T., Jakob, T., Kinaciyan, T., Kromminga, A., Konstantinou, G. N. Makris, M., Metz, M., Stahl Skov, P., Staubach, P., Sussman, G., Zhang, K., and Maurer, M.+: Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria. Allergy Asthma Immunol. Res. 2021: 13; 545-559. IF: 5.10 |
o.414
|
439. |
Bizjak, M., Maurer, M.+, Košnik, M., Terhorst-Molawi, D., Zver, S., Burmeister, T., and Siebenhaar, F.: Severe cold urticaria can point to an underlying clonal mast cell disorder. Allergy 2021: 76; 2609-2613. IF: 14.71 |
o.439
| 11. | Maurer, M., Siebenhaar, F., Syska, W., and Magerl, M.: Ätiopathogenese der akuten und der chronischen Urtikaria. Allergo J. 2006: 15; 199-204. IF: N/A |
|
176. |
Levi-Schaffer, F.+, Gibbs, B. F., Hallgren, J., Pucillo, C., Redegeld, F., Siebenhaar, F., Vitte, J., Mezouar, S., Michel, M., Puzzovio, P. G., and Maurer, M.+: Selected recent advances in understanding the role of of human mast cells in health and disease. J. Allergy Clin. Immunol. 2022: 149; 1833-1844. IF: 14.20 |
r.176
|
179. |
Kolkhir, P., Komi, D. E. A., Metz, M., Siebenhaar, F., and Maurer, M.+: Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases. Nat. Rev. Immunol. 2022: 22; 294-308. IF: 100.30 |
r.179
| 230 | Hartmann, K.+, Escribano, L., Grattan, C., Brockow, K., Carter, M. C., Alvarez-Twose, I., Matito, A., Broesby-Olsen, S., Siebenhaar, F., Lange, M., Niedoszytko, M., Castells, M., Oude Elberink, J. N. G., Bonadonna, P., Zanotti, R., Hornick, J. L., Torrelo, A., Grabbe, J., Rabenhorst, A., Nedoszytko, B., Butterfield, J. H., Gotlib, J., Reiter, A., Radia, D., Hermine, O., Sotlar, K., George, T. I., Kristensen, T. K., Kluin-Nelemans, H. C., Yavuz, S., Hägglung, H., Sperr, W. R., Schwartz, L. B., Triggiani, M., Maurer, M. Nilsson, G., Horny, H. P., Arock, M., Orfao, A., Metcalfe, D. D., Akin, C., and Valent, P.: Cutaneous manifestations in mastocytosis: consensus report of the European Competence Network on Mastocytosis (ECNM), AAAAI and EAACI. J. Allergy Clin. Immunol. 2016: 137; p35-45. IF: 13.08 |
| 152(a) | Maurer, M. Rosén, K.+, and Hsie, H. J.: Comment on Omalizumab for chronic urticaria. New Engl. J. Med. 2013: 368; 2527-2530 |
|
597. |
Pyatilova, P., Hackler, Y., Aulenbacher, F., Asero, R., Bauer, A., Bizjak, M., Day, C., Dissemond, J., Du-Thanh, A., Fomina, D., Giménez-Arnau, A., Grattan, C., Gregoriou, S., Hawro, T., Kasperska-Zajac, A., Khoshkhui, M., Kocatürk, E., Kovalkova, E., Kulthanan, K., Kuznetsova, E., Makris, M., Mukhina, O., Pesqué, D., Peter, J., Salameh, P., Siebenhaar, F., Sikora, A., Staubach, P., Tuchinda, P., Zamłyński, M., Weller, K., Maurer, M., and Kolkhir, P.+: Non-skin-related symptoms are common in chronic spontaneous urticaria and linked to active and uncontrolled disease: results from CURE. J. Allergy Clin. Immunol. Pract. 2024: 12; 1890-1899. IF: TBD (IF 2023: 8.20) |
o.597